<html><head><title>EC 3.4.21.118</title></head><base href="http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/21/118.html"><body><center><b>IUBMB Enzyme Nomenclature</b><p><h1><b>EC 3.4.21.118</b></h1></center><b>Accepted name:</b> kallikrein 8<p><b>Reaction:</b> Cleavage of amide substrates following the basic amino acids Arg or Lys at the P1 position, with a preference for Arg over Lys<p><b>Other name(s):</b> KLK8; PRSS19; human kallikrein 8; hK8; mK8; ovasin; tumor-associated differentially expressed gene 14; TADG-14; NP; neuropsin<p><b>Comments:</b> The enzyme is activated by removal of an N-terminal prepropeptide [2,4]. The highest amidolytic activity is observed using Boc-Val-Pro-Arg<img src="../../../EZgif/FISS.GIF" align=top>7-amido-4-methylcoumarin, which is a substrate of &alpha;-thrombin [2,4]. Substrates lacking basic amino acids in the P1 position are not cleaved [4]. The enzyme degrades casein, fibronectin, gelatin, collagen type IV, fibrinogen, and high-molecular-mass kininogen [3] and is associated with diseases such as ovarian cancer and Alzheimer's disease [4]. Belongs in peptidase family <a href="http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=S1A " target="new">S1A</a>.<p><b>Links to other databases:</b> <a href="http://www.brenda-enzymes.org/enzyme.php?ecno=3.4.21.118" target="new">BRENDA</a>, <a href="http://enzyme.expasy.org/EC/3.4.21.118" target="new">EXPASY</a>, <a href="http://www.genome.ad.jp/dbget-bin/www_bget?ec:3.4.21.118" target="new">KEGG</a>,  <a target = "new" href="http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=S01.244">MEROPS</a>, <a href="http://www.metacyc.org/META/NEW-IMAGE?type=EC-NUMBER&object=EC-3.4.21.118" target="new">Metacyc</a>,<a target="new" href="http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/enzymes/GetPage.pl?ec_number=3.4.21.118">PDB</a>, CAS registry number: 171715-15-4<p><b>References:</b><p>1. Chen, Z.L., Yoshida, S., Kato, K., Momota, Y., Suzuki, J., Tanaka, T., Ito, J., Nishino, H., Aimoto, S., Kiyama, H. and Shiosaka, S. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. <i>J. Neurosci.</i> 15 (1995) 5088-5097. [PMID: <a href="http://www.ncbi.nlm.nih.gov:80/pubmed/7623137?dopt=Abstract" target="new">7623137</a>]<p>2. Shimizu, C., Yoshida, S., Shibata, M., Kato, K., Momota, Y., Matsumoto, K., Shiosaka, T., Midorikawa, R., Kamachi, T., Kawabe, A. and Shiosaka, S. Characterization of recombinant and brain neuropsin, a plasticity-related serine protease. <i>J. Biol. Chem.</i> 273 (1998) 11189-11196. [PMID: <a href="http://www.ncbi.nlm.nih.gov:80/pubmed/9556608?dopt=Abstract" target="new">9556608</a>]<p>3. Rajapakse, S., Ogiwara, K., Takano, N., Moriyama, A. and Takahashi, T. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. <i>FEBS Lett.</i> 579 (2005) 6879-6884. [PMID: <a href="http://www.ncbi.nlm.nih.gov:80/pubmed/16337200?dopt=Abstract" target="new">16337200</a>]<p>4. Kishi, T., Cloutier, S.M., K&uuml;ndig, C., Deperthes, D. and Diamandis, E.P. Activation and enzymatic characterization of recombinant human kallikrein 8. <i>Biol. Chem.</i> 387 (2006) 723-731. [PMID: <a href="http://www.ncbi.nlm.nih.gov:80/pubmed/16800733?dopt=Abstract" target="new">16800733</a>]<p><center><small>[EC 3.4.21.118 created 2006]</small></center><p><hr>Return to <a href="../21/">EC 3.4.21 home page</a><br>Return to <a href="../">EC 3.4 home page</a><br>Return to <a href="../../">EC 3 home page</a><br>Return to <a href="../../../">Enzymes home page</a><br>Return to <a href="../../../../">IUBMB Biochemical Nomenclature home page</a><p></body></html>